Show
Sort by
-
- Journal Article
- A1
- open access
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
-
COVID‐19 pandemic : practical considerations on the organization of an allergy clinic : an EAACI/ARIA position paper
-
- Journal Article
- A1
- open access
Management of anaphylaxis due to COVID‐19 vaccines in the elderly
-
- Journal Article
- A1
- open access
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
-
Allergic rhinitis
-
- Journal Article
- A2
- open access
Managing allergic rhinitis in the pharmacy : an ARIA guide for implementation in practice
-
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air (R) App
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients : an ARIA-EAACI statement
-
Handling of allergen immunotherapy in the COVID-19 pandemic : an ARIA-EAACI statement
-
Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
-
- Journal Article
- A1
- open access
Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies
-
- Journal Article
- A1
- open access
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
-
From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity